Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations

Journal of Drugs in Dermatology

Volumn 9, Issue 5, 2010, Pages 482-487

  Harper, Julie C ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE PLUS BENZOYL PEROXIDE; BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN; CLINDAMYCIN; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT; RETINOID;

ACNE; ARTICLE; BURNING SENSATION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; HUMAN; MONOTHERAPY; PATIENT COMPLIANCE; PRURITUS; SKIN IRRITATION; TREATMENT OUTCOME; ACNE VULGARIS; ANIMAL; DOSE RESPONSE; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RETINOIDS;

EID: 77953158714     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Burkhart CG, Burkhart CN. Antibacterial properties of soluble benzoyl peroxide. Int J Dermatol. 2008;47:301-302. (Pubitemid 351266856)
2. Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: New perspectives on formulation and utilization. Dermatol Clin. 2009;27:17-24.
3. Tanghetti E. The evolution of benzoyl peroxide therapy. Cutis. 2008;82 (5 Suppl) :5-11.
4. Cox RM, Ciufo LR, inventors; Stiefel Laboratories, Inc, assignee. Stable benzoyl peroxide composition. US Patent 3,535,422. October 20, 1970.
5. Fulton JE Jr, inventor; AHC Pharmacal, Inc. assignee. Composition and method for the treatment of acne. US Patent 4,189,501. February 19, 1980.
6. Ozer O, Ozcan I, Catin EO et al. Evaluation of in vitro release and skin irritation of benzoyl peroxide-containing products. J Drug Del Sci Tech. 2006;16:449-454. (Pubitemid 46122253)
7. Mills OH Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5% and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986:25:664-667. (Pubitemid 17210594)
8. Kligman AM. Acne vulgaris: Tricks and treatments. Part II: The benzoyl peroxide saga. Cutis. 1995;56:260-261.
9. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology. 1998;196:119-125. (Pubitemid 28116058)
10. Waller JM, Dreher F, Behnam S, et al. "Keratolytic" properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol. 2006;19:283-289. (Pubitemid 44329095)
11. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1-S37. (Pubitemid 36791495)
12. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: Focus on antibiotic resistance. Cutis. 2007;79(Suppl 6):9-25.
13. Cove JH, Holland KT. The effect of benzoyl peroxide on cutaneous micro-organisms in vitro. J Appl Bacteriol. 1983;54:379-382. (Pubitemid 13066056)
14. Bollinger JN, Rowlands JR, Gause EM. Reaction mechanism of persodox. Southwest Research Institute; personal communication.
15. Cited in: Fulton JE Jr, Farzad-Bakshandeh A, Bradley S. Studies on the mechanism of action to topical benzoyl peroxide and vitamin A acid in acne vulgaris. J Cutan Pathol. 1974;1:191-200.
16. Burkhart CN, Burkhart CG. Genome sequence of Propionibacterium acnes reveals immunogenic and surface-associated genes confirming existence of the acne biofilm. Int J Dermatol. 2006;45:872. (Pubitemid 43984405)
17. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60:S1-S50.
18. Gloor M. Benzolyperoxid in der dermatologischen Lokaltherapie. Zentralbl Hautkr. 1990:157:1010-1015
19. Pierard GE, Pierard-Franchimont C, Goffin V. Digital image analysis of microcomedones. Dermatology. 2003;206:29-36
20. Zouboulis CC. Moderne akenetherapie. Akt Dermatol. 2003:29:49-57
21. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology. 1998:196:119-125 (Pubitemid 28116058)
22. Dosik J. Varnvakias G. Comparative irritation potential of two combination acne products. Am J Clin Dermatol. 2008; 9(5):313-33.
23. Draelos ZD. Improving compliance in acne treatment: benzoyl peroxide considerations. Cutis. 2008; 82(5 Suppl):17-20.
24. Draelos ZD. Therapeutic moisturizers. Dermatol Clin. 2000;18:597-607.
25. Tucker R, Walton S. The role of benzoyl peroxide in the management of acne vulgaris. Pharm J. 2007;279:48-53. (Pubitemid 47162496)
26. Kligman AM, Leyden JJ, Stewart R. New uses for benzoyl peroxide: A broad-spectrun antimicrobial agent. Int J Dermatol 1997; 6(5); 413-417
27. do Nascimento LV, Guedes AC, Magalháes GM, et al. Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% gel (QD) in the treatment of acne vulgaris for 11 weeks. J Dermatolog Treat. 2003;14:166-171. (Pubitemid 37254629)
28. Gans EH, Kligman AM. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes. J Dermatolog Treat. 2002;13:107-110.
29. Eady EA, Farmery MR, Ross JI, et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol. 1994;131:331-336. (Pubitemid 24290215)
30. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol. 1996;134:107-113. (Pubitemid 26030998)
31. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24:1117-1133. (Pubitemid 34833234)
32. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: Combined results of two double-blind investigations. J Am Acad Dermatol. 1997;37:590-595. (Pubitemid 27446730)
33. Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac®) and erythromycin + zinc acetate (Zineryt®) in the treatment of mild to moderate facial acne vulgaris. J EurAcad Dermatol Venereol. 2007;21:311-319.
34. Leyden J. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction. Cutis. 2001;67:5-7.
35. Bucks D, Sarpotdar P, Yu K, et al. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. J Drugs Dermatol. 2009;8:634-638.
36. Thiboutot D, Zaenglein A, Weiss J, et al. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol. 2008;59:792-800.
37. Shalita A. The integral role of topical andoral retinoids in the early treatment of acne. J Eur Acad Dermatol Venereol. 2001;15:(Suppl 3):43-49. (Pubitemid 34036871)
38. Epiduo™ [package insert]. Fort Worth, TX: Galderma Laboratories; 2008.
39. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139(Suppl 52):8-11. (Pubitemid 28475277)
40. Pariser DM, Westmoreland P, Morris A, et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:899-905.
41. Thiboutot DM, Bucko A, Eichenfield L, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007; 57:791-799. (Pubitemid 47553072)